Page last updated: 2024-10-28

miltefosine and Guillain-Barre Syndrome

miltefosine has been researched along with Guillain-Barre Syndrome in 1 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Guillain-Barre Syndrome: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, N1
Pandey, K1
Das, VN1
Sinha, PK1
Topno, RK1
Lal, CS1
Bimal, S1
Verma, N1
Das, P1

Other Studies

1 other study available for miltefosine and Guillain-Barre Syndrome

ArticleYear
HIV infection, visceral leishmaniasis and Guillain-Barré syndrome in the same patient: a case report.
    Annals of tropical medicine and parasitology, 2008, Volume: 102, Issue:2

    Topics: Adult; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fatal Outcome; Guillain-Barre Syndro

2008